Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

被引:46
作者
Giatromanolaki, A
Koukourakis, MI
Simopoulos, C
Polychronidis, A
Sivridis, E
机构
[1] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece
[3] Democritus Univ Thrace, Dept Surg, Alexandroupolis, Greece
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2003年 / 29卷 / 10期
关键词
gallbladder carcinoma; VEGF; angiogenesis; prognosis;
D O I
10.1016/j.ejso.2003.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aim: To investigate the angiogenic and prognostic role of vascular enclothelial growth factor (VEGF) in operable gallbladder carcinomas. Methods: Sixty patients with early gallbladder carcinomas, treated with surgery alone, were investigated immunohistochemically for the expression of VEGF, thymidine phosphorylase (TP) and new blood vessel formation. The results were correlated with clinico-pathological features and prognosis. Results: An increased VEGF secretion in gallbladder carcinomas was significantly associated with increased angiogenesis but not with patients survival, although high angiogenesis did relate with poor prognosis. TP was also associated with angiogenesis, but only the combined VEGF/TP expression was associated with unfavourable survival. Histological grade was another independent factor of prognosis. Conclusion: Both VEGF and TP expression are associated with high rate of angiogenesis, a factor directly associated with prognosis. The combined expression of these angiogenic factors confer a particularly poor post-operative outcome, speculature. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 23 条
[1]
BOSSET JF, 1989, CANCER, V64, P1843, DOI 10.1002/1097-0142(19891101)64:9<1843::AID-CNCR2820640915>3.0.CO
[2]
2-N
[3]
Anti-angiogenic agents: clinical trial design and therapies in development [J].
Deplanque, G ;
Harris, AL .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1713-1724
[4]
DONOHUE JH, 1990, ARCH SURG-CHICAGO, V125, P237
[5]
Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe [J].
Faivre, J ;
Forman, D ;
Estève, J ;
Obradovic, M ;
Sant, M .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (14) :2184-2190
[6]
The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[7]
FLICKINGER JC, 1991, CANCER, V68, P289, DOI 10.1002/1097-0142(19910715)68:2<289::AID-CNCR2820680213>3.0.CO
[8]
2-2
[9]
Geng L, 2001, CANCER RES, V61, P2413
[10]
Thymidine phosphorylase expression in gallbladder adenocarcinomas [J].
Giatromanolaki, A ;
Sivridis, E ;
Simopoulos, C ;
Polychronidis, A ;
Gatter, KC ;
Harris, AL ;
Koukourakis, MI .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2002, 10 (03) :181-188